BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19637187)

  • 21. Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes.
    Lautamäki R; Borra R; Iozzo P; Komu M; Lehtimäki T; Salmi M; Jalkanen S; Airaksinen KE; Knuuti J; Parkkola R; Nuutila P
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E282-90. PubMed ID: 16478772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin-converting enzyme inhibitors improve hepatic steatosis by modulating expression of tumour necrosis factor-alpha, interleukin-6 and adiponectin receptor-2 in rats with type 2 diabetes.
    Zhang X; Li ZZ; Liu DF; Xu X; Mei ZC; Shen W
    Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):631-6. PubMed ID: 19076162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic fat is not associated with beta-cell function or postprandial free fatty acid response.
    Rijkelijkhuizen JM; Doesburg T; Girman CJ; Mari A; Rhodes T; Gastaldelli A; Nijpels G; Dekker JM
    Metabolism; 2009 Feb; 58(2):196-203. PubMed ID: 19154952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An observational study of reduction of insulin resistance and prevention of development of type 2 diabetes mellitus in women with polycystic ovary syndrome treated with metformin and diet.
    Glueck CJ; Goldenberg N; Sieve L; Wang P
    Metabolism; 2008 Jul; 57(7):954-60. PubMed ID: 18555837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
    Ruge T; Lockton JA; Renstrom F; Lystig T; Sukonina V; Svensson MK; Eriksson JW
    Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No difference between high-fructose and high-glucose diets on liver triacylglycerol or biochemistry in healthy overweight men.
    Johnston RD; Stephenson MC; Crossland H; Cordon SM; Palcidi E; Cox EF; Taylor MA; Aithal GP; Macdonald IA
    Gastroenterology; 2013 Nov; 145(5):1016-1025.e2. PubMed ID: 23872500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic and bioinformatic analysis of membrane proteome in type 2 diabetic mouse liver.
    Kim GH; Park EC; Yun SH; Hong Y; Lee DG; Shin EY; Jung J; Kim YH; Lee KB; Jang IS; Lee ZW; Chung YH; Choi JS; Cheong C; Kim S; Kim SI
    Proteomics; 2013 Apr; 13(7):1164-79. PubMed ID: 23349036
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Constant hepatic ATP concentrations during prolonged fasting and absence of effects of Cerbomed Nemos
    Gancheva S; Bierwagen A; Markgraf DF; Bönhof GJ; Murphy KG; Hatziagelaki E; Lundbom J; Ziegler D; Roden M
    Mol Metab; 2018 Jan; 7():71-79. PubMed ID: 29122559
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of intranasal insulin on hepatic fat accumulation and energy metabolism in humans.
    Gancheva S; Koliaki C; Bierwagen A; Nowotny P; Heni M; Fritsche A; Häring HU; Szendroedi J; Roden M
    Diabetes; 2015 Jun; 64(6):1966-75. PubMed ID: 25576060
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fasting Whole-Body Energy Homeostasis and Hepatic Energy Metabolism in Nondiabetic Humans with Fatty Liver.
    Lattuada G; Radaelli MG; De Cobelli F; Esposito A; Manzoni G; Perra S; Del Maschio A; Castoldi G; Perseghin G
    Oxid Med Cell Longev; 2019; 2019():9796175. PubMed ID: 31097978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Absolute Quantification of Phosphor-Containing Metabolites in the Liver Using
    Pfleger L; Gajdošík M; Wolf P; Smajis S; Fellinger P; Kuehne A; Krumpolec P; Trattnig S; Winhofer Y; Krebs M; Krššák M; Chmelík M
    J Magn Reson Imaging; 2019 Feb; 49(2):597-607. PubMed ID: 30291654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lower fasting muscle mitochondrial activity relates to hepatic steatosis in humans.
    Szendroedi J; Kaul K; Kloock L; Straßburger K; Schmid AI; Chmelik M; Kacerovsky M; Kacerovsky-Bielesz G; Prikoszovich T; Brehm A; Krssák M; Gruber S; Krebs M; Kautzky-Willer A; Moser E; Pacini G; Roden M
    Diabetes Care; 2014 Feb; 37(2):468-74. PubMed ID: 24026561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men.
    Petersen KF; Dufour S; Feng J; Befroy D; Dziura J; Dalla Man C; Cobelli C; Shulman GI
    Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18273-7. PubMed ID: 17114290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-dimensional high-resolution magnetic resonance spectroscopic imaging for absolute quantification of 31P metabolites in human liver.
    Chmelík M; Schmid AI; Gruber S; Szendroedi J; Krssák M; Trattnig S; Moser E; Roden M
    Magn Reson Med; 2008 Oct; 60(4):796-802. PubMed ID: 18816829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced basal ATP synthetic flux of skeletal muscle in patients with previous acromegaly.
    Szendroedi J; Zwettler E; Schmid AI; Chmelik M; Pacini G; Kacerovsky G; Smekal G; Nowotny P; Wagner O; Schnack C; Schernthaner G; Klaushofer K; Roden M
    PLoS One; 2008; 3(12):e3958. PubMed ID: 19093000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic Steatosis Is Associated With Adverse Molecular Signatures in Subjects Without Diabetes.
    Pietzner M; Budde K; Homuth G; Kastenmüller G; Henning AK; Artati A; Krumsiek J; Völzke H; Adamski J; Lerch MM; Kühn JP; Nauck M; Friedrich N
    J Clin Endocrinol Metab; 2018 Oct; 103(10):3856-3868. PubMed ID: 30060179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Absolute Quantification of Human Liver Phosphorus-Containing Metabolites In Vivo Using an Inhomogeneous Spoiling Magnetic Field Gradient.
    Bashir A; Gropler R; Ackerman J
    PLoS One; 2015; 10(12):e0143239. PubMed ID: 26633549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 15-Hydroxyprostaglandin dehydrogenase inhibitor SW033291 ameliorates hepatic abnormal lipid metabolism, ER stress, and inflammation through PGE
    Wang W; Liang M; Wang L; Bei W; Guo J
    Bioorg Chem; 2023 Aug; 137():106646. PubMed ID: 37285764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired mitochondrial function and insulin resistance of skeletal muscle in mitochondrial diabetes.
    Szendroedi J; Schmid AI; Meyerspeer M; Cervin C; Kacerovsky M; Smekal G; Gräser-Lang S; Groop L; Roden M
    Diabetes Care; 2009 Apr; 32(4):677-9. PubMed ID: 19131470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Skeletal muscle phosphodiester content relates to body mass and glycemic control.
    Szendroedi J; Schmid AI; Chmelik M; Krssak M; Nowotny P; Prikoszovich T; Kautzky-Willer A; Wolzt M; Waldhäusl W; Roden M
    PLoS One; 2011; 6(7):e21846. PubMed ID: 21779337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.